Medicare billing address
CMS Medicare provider billing file
1800 Mulberry StScranton, PA 18510
CMS public data · NPI 1679668214
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Peter J Cawley, MD
Specialty
Credential
MD
NPI
1679668214
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Peter J Cawley, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1800 Mulberry StCMS Doctors & Clinicians file
100 N Academy AveCMS Doctors & Clinicians file
255 Route 220 HwyIn the 2024 CMS provider billing file, this NPI had 1,755 Medicare beneficiaries and 2,970 total services. The average beneficiary age was 74, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$105,579.33
Total Medicare payment amount
$79,115.48
Medicare beneficiaries
1,755
Total services
2,970
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
45%
CMS beneficiary-panel share
Diabetes
37%
CMS beneficiary-panel share
Atrial fibrillation
36%
CMS beneficiary-panel share
Chronic kidney disease
34%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,046 | $7.62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 458 | $64.30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 241 | $7.65 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 150 | $74.65 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 140 | $123.72 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 130 | $2.89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $74.20 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 85 | $91.46 |
| Ultrasound of heart, follow-up | 72 | $23.08 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 70 | $6.63 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1679668214. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Metoprolol Succinate | Metoprolol Succinate | 160 | 426.5 | $3,548.64 |
| 2 | Rosuvastatin Calcium | Rosuvastatin Calcium | 140 | 336.9 | $2,362.88 |
| 3 | Eliquis | Apixaban | 128 | 275.5 | $154,324.26 |
| 4 | Atorvastatin Calcium | Atorvastatin Calcium | 93 | 257.7 | $1,245.08 |
| 5 | Repatha Sureclick | Evolocumab | 91 | 98.2 | $53,283.35 |
| 6 | Ezetimibe | Ezetimibe | 69 | 196 | $2,081.53 |
| 7 | Amlodipine Besylate | Amlodipine Besylate | 61 | 174.7 | $770.21 |
| 8 | Furosemide | Furosemide | 57 | 165 | $316.47 |
| 9 | Metoprolol Tartrate | Metoprolol Tartrate | 54 | 140 | $402.24 |
| 10 | Carvedilol | Carvedilol | 46 | 102 | $703.90 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Georgetown University School Of Medicine
Graduation year
2000
Group/practice field
Geisinger Clinic
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.